PURISYS Trademark

Trademark Overview


On Thursday, September 19, 2019, a trademark application was filed for PURISYS with the United States Patent and Trademark Office. The USPTO has given the PURISYS trademark a serial number of 88623475. The federal status of this trademark filing is SU - RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Tuesday, July 26, 2022. This trademark is owned by Noramco, Inc.. The PURISYS trademark is filed in the Chemical Products category with the following description:

Active chemical ingredients for use in the manufacture of pharmaceuticals for treating physical and mental disorders in the nature of epilepsy, convulsions, seizures, nerve damage, pain, chronic pain, inflammation, acne, psoriasis, heart disease, hypertension, coronary artery disease (atherosclerosis), muscle disorders, muscle spasms, bone deficiency, Parkinson disease, Crohn disease, multiple sclerosis, immune disorders, fungal infections, bacterial infections, nausea, vomiting, appetite loss, small intestine disorders, diabetes, high blood sugar, cancer and side effects from the treatment of cancer, Huntington disease, symptoms of withdrawal, temporomandibular disorders, insomnia, trouble sleeping, anxiety, depression, schizophrenia, and bipolar disorder
purisys

General Information


Serial Number88623475
Word MarkPURISYS
Filing DateThursday, September 19, 2019
Status814 - SU - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateTuesday, July 26, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 11, 2020

Trademark Statements


Goods and ServicesActive chemical ingredients for use in the manufacture of pharmaceuticals for treating physical and mental disorders in the nature of epilepsy, convulsions, seizures, nerve damage, pain, chronic pain, inflammation, acne, psoriasis, heart disease, hypertension, coronary artery disease (atherosclerosis), muscle disorders, muscle spasms, bone deficiency, Parkinson disease, Crohn disease, multiple sclerosis, immune disorders, fungal infections, bacterial infections, nausea, vomiting, appetite loss, small intestine disorders, diabetes, high blood sugar, cancer and side effects from the treatment of cancer, Huntington disease, symptoms of withdrawal, temporomandibular disorders, insomnia, trouble sleeping, anxiety, depression, schizophrenia, and bipolar disorder

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, September 26, 2019
Primary Code001
First Use Anywhere DateSaturday, February 29, 2020
First Use In Commerce DateSaturday, February 29, 2020

Trademark Owner History


Party NamePURISYS LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressATHENS, GA 30601

Party NamePURISYS LLC
Party Type11 - New Owner Before Publication
Legal Entity Type16 - Limited Liability Company
AddressATHENS, GA 30601

Party NameNoramco, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWilmington, DE 19809

Trademark Events


Event DateEvent Description
Tuesday, July 26, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 25, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 25, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 22, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 22, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, July 22, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 22, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, January 24, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 24, 2022NON-FINAL ACTION E-MAILED
Monday, January 24, 2022SU - NON-FINAL ACTION - WRITTEN
Wednesday, December 15, 2021ASSIGNED TO EXAMINER
Wednesday, December 1, 2021ASSIGNED TO EXAMINER
Wednesday, October 20, 2021STATEMENT OF USE PROCESSING COMPLETE
Wednesday, October 6, 2021USE AMENDMENT FILED
Wednesday, October 20, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 6, 2021TEAS STATEMENT OF USE RECEIVED
Thursday, April 8, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 6, 2021SOU EXTENSION 1 GRANTED
Tuesday, April 6, 2021SOU EXTENSION 1 FILED
Tuesday, April 6, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, October 6, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 11, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 11, 2020PUBLISHED FOR OPPOSITION
Wednesday, July 22, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, July 9, 2020ASSIGNED TO LIE
Friday, July 3, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 30, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 30, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 30, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 1, 2020ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, January 22, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, January 15, 2020ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, December 30, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 30, 2019NON-FINAL ACTION E-MAILED
Monday, December 30, 2019NON-FINAL ACTION WRITTEN
Thursday, December 19, 2019ASSIGNED TO EXAMINER
Thursday, September 26, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 23, 2019NEW APPLICATION ENTERED